IMMP, page-11

Might Gobblieb have found out about this at that New York business

conference where Immutep presented 3 months or so back....

I would imagine that's where Renaissance also found out...

It should be acknowledged these instos of late are focused

on value over time and are prepared to let the company run

its due coarse to an extent.....

It is also important to understand these biotech investors

well and truly do their own due diligence before buying in,

unlike a sabby type who in reality are only large day traders

with no scruples...